↓ Skip to main content

PLOS

Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone

Overview of attention for article published in PLOS ONE, April 2009
Altmetric Badge

Mentioned by

patent
12 patents

Readers on

mendeley
110 Mendeley
citeulike
1 CiteULike
Title
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
Published in
PLOS ONE, April 2009
DOI 10.1371/journal.pone.0005275
Pubmed ID
Authors

Khalid S. Mohammad, Carol G. Chen, Guive Balooch, Elizabeth Stebbins, C. Ryan McKenna, Holly Davis, Maria Niewolna, Xiang Hong Peng, Daniel H. N. Nguyen, Sophi S. Ionova-Martin, John W. Bracey, William R. Hogue, Darren H. Wong, Robert O. Ritchie, Larry J. Suva, Rik Derynck, Theresa A. Guise, Tamara Alliston

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 <1%
United States 1 <1%
Sweden 1 <1%
Germany 1 <1%
Unknown 106 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 19%
Student > Ph. D. Student 21 19%
Student > Master 13 12%
Professor 10 9%
Professor > Associate Professor 8 7%
Other 20 18%
Unknown 17 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 24 22%
Agricultural and Biological Sciences 23 21%
Medicine and Dentistry 19 17%
Engineering 12 11%
Materials Science 6 5%
Other 5 5%
Unknown 21 19%